How AI and a Menopause Drug Could Revolutionize Breast Cancer Prevention
- Georgie Kovacs
- 9 minutes ago
- 2 min read

Episode Summary: Breast Cancer Prevention Just Took Two Big Steps Forward
In this short but powerful episode, Georgie breaks down two groundbreaking developments in breast cancer prevention that could reshape how we think about screening, menopause care, and early intervention:
An FDA-authorized AI tool—Clairity Breast—that predicts a woman’s five-year breast cancer risk from a standard mammogram, even when it appears normal.
A menopause drug, Duavee, that may help prevent invasive breast cancer in women with a history of high-risk lesions like DCIS.
These tools aren’t just high-tech—they’re practical, accessible, and represent a smarter, more equitable approach to women’s health.
Whether you're a clinician, policymaker, or woman navigating your own care, this episode breaks down what you need to know.
What You'll Learn in This Episode
FDA-Approved AI for Breast Cancer Risk Prediction
What Clairity Breast is and how it works
Why it matters for women under 50
How it fits into current mammogram workflows
Timeline for rollout and insurance coverage considerations
Menopause Drug Duavee and Breast Cancer Prevention
New clinical trial results shared at the ASCO 2025 meeting
Why this treatment could benefit women with DCIS or other precancerous lesions
What clinicians and high-risk patients should be asking now
Duavee’s current FDA status and reimbursement landscape
The Bigger Picture: Why This Is a Turning Point in Women's Health
What these two tools signal about the future of precision and prevention
How they're designed to work in real-world care—not just research labs
Why this episode matters for people advocating for smarter, faster, fairer care
Who This Episode Is For
Women navigating breast cancer risk or menopause decisions
Clinicians, radiologists, and OB-GYNs focused on patient-centered care
Healthcare innovators, startup leaders, and payers interested in smarter early intervention
Policy leaders and health equity advocates
Resources & References
Read about Clairity Breast – FDA De Novo authorization details
Learn about Duavee – Clinical trial results presented at ASCO 2025
Check out the blog post of this episode: Breast Cancer Prevention Just Leveled Up: What Two Breakthroughs Mean for the Future of Women’s Health
Help Spread the Word
If this episode helped you understand the future of breast cancer prevention, share it with a friend or clinician who needs to hear it.
If you want to support this women’s health podcast, leave a review for Fempower Health on iTunes or Spotify.
Spread the awareness and share this episode with someone you know!
Support and connect with the Fempower Health community:
Subscribe to the Fempower Health Podcast for new episodes every Tuesday
Visit us online at www.fempower-health.com
Sign up for our weekly newsletter for the latest announcements, news, and research
Email us for inquiries & outreach: info@fempower-health.com
Disclaimer
The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.
Comments